BioAegis Therapeutics and EastHORN Expand Phase 2 COVID-19 Clinical Trial within Spain and into Romania
BioAegis’ Phase 2 clinical trial of recombinant human plasma...
EastHORN’s response to the coronavirus Covid-19 crisis
Our priorities at this challenging time are the well-being o...
Pavla Nevolová – Country Head, EastHORN Czech Republic – recent interview in Pharma Boardroom
Pavla Nevolová, country head of EastHORN in the Czech Republ...
EastHORN joining the global fight against Coronavirus
At EastHORN, a European CRO, we are joining the global fight...
Covid-19 Pandemic
The Covid-19 pandemic is now upon us in Europe and we want t...